{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:58:35Z","timestamp":1777492715924,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-024-02330-5","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T18:15:05Z","timestamp":1709835305000},"page":"2295-2303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Peritoneal metastases in patients with neuroendocrine neoplasms: a challenging site of metastases with clinical and prognostic implications"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6013-5893","authenticated-orcid":false,"given":"M.","family":"Tsoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Armonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Kamieniarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Thuringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mirnezami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Caplin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kaltsas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Toumpanakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"issue":"18","key":"2330_CR1","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A et al (2008) One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26(18):3063\u20133072. https:\/\/doi.org\/10.1200\/JCO.2007.15.4377","journal-title":"J Clin Oncol"},{"issue":"2","key":"2330_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000443167","volume":"103","author":"M Pavel","year":"2016","unstructured":"Pavel M, O\u2019Toole D, Costa F, Capdevila J, Gross D, Kianmanesh R, Krenning E, Knigge U, Salazar R, Pape UF et al (2016) ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology 103(2):172\u2013185. https:\/\/doi.org\/10.1159\/000443167","journal-title":"Neuroendocrinology"},{"issue":"10","key":"2330_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, Shih, T.: Yao, J.C. (2017) Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 3(10):1335\u20131342. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0589","journal-title":"JAMA Oncol"},{"issue":"8","key":"2330_CR4","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1245\/s10434-016-5734-x","volume":"24","author":"A Madani","year":"2017","unstructured":"Madani A, Thomassen I, van Gestel Y, van der Bilt JDW, Haak HR, de Hingh I, Lemmens V (2017) Peritoneal metastases from gastroenteropancreatic neuroendocrine tumors: incidence, risk factors and prognosis. Ann Surg Oncol 24(8):2199\u20132205. https:\/\/doi.org\/10.1245\/s10434-016-5734-x","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"2330_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.surg.2004.11.007","volume":"137","author":"D Elias","year":"2005","unstructured":"Elias D, Sideris L, Liberale G, Ducreux M, Malka D, Lasser P, Duvillard P, Baudin E (2005) Surgical treatment of peritoneal carcinomatosis from well-differentiated digestive endocrine carcinomas. Surgery 137(4):411\u2013416. https:\/\/doi.org\/10.1016\/j.surg.2004.11.007","journal-title":"Surgery"},{"issue":"8","key":"2330_CR6","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/(SICI)1097-0142(19961015)78:8<1686::AID-CNCR8>3.0.CO;2-C","volume":"78","author":"B Vasseur","year":"1996","unstructured":"Vasseur B, Cadiot G, Zins M, Flejou JF, Belghiti J, Marmuse JP, Vilgrain V, Bernades P, Mignon M, Ruszniewski P (1996) Peritoneal carcinomatosis in patients with digestive endocrine tumors. Cancer 78(8):1686\u20131692","journal-title":"Cancer"},{"issue":"4","key":"2330_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000286700","volume":"91","author":"R Kianmanesh","year":"2010","unstructured":"Kianmanesh R, Ruszniewski P, Rindi G, Kwekkeboom D, Pape UF, Kulke M, Sevilla Garcia I, Scoazec JY, Nilsson O, Fazio N et al (2010) ENETS consensus guidelines for the management of peritoneal carcinomatosis from neuroendocrine tumors. Neuroendocrinology 91(4):333\u2013340. https:\/\/doi.org\/10.1159\/000286700","journal-title":"Neuroendocrinology"},{"issue":"6","key":"2330_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/jso.23399","volume":"108","author":"JT Au","year":"2013","unstructured":"Au JT, Levine J, Aytaman A, Weber T, Serafini F (2013) Management of peritoneal metastasis from neuroendocrine tumors. J Surg Oncol 108(6):385\u2013386. https:\/\/doi.org\/10.1002\/jso.23399","journal-title":"J Surg Oncol"},{"issue":"6","key":"2330_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1159\/000503144","volume":"110","author":"E Merola","year":"2020","unstructured":"Merola E, Prasad V, Pascher A, Pape UF, Arsenic R, Denecke T, Fehrenbach U, Wiedenmann B, Pavel ME (2020) Peritoneal carcinomatosis in gastro-entero-pancreatic neuroendocrine neoplasms: clinical impact and effectiveness of the available therapeutic options. Neuroendocrinology 110(6):517\u2013524. https:\/\/doi.org\/10.1159\/000503144","journal-title":"Neuroendocrinology"},{"issue":"10","key":"2330_CR10","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.ejso.2009.02.010","volume":"35","author":"HA Swellengrebel","year":"2009","unstructured":"Swellengrebel HA, Zoetmulder FA, Smeenk RM, Antonini N, Verwaal VJ (2009) Quantitative intra-operative assessment of peritoneal carcinomatosis\u2014a comparison of three prognostic tools. Eur J Surg Oncol 35(10):1078\u20131084. https:\/\/doi.org\/10.1016\/j.ejso.2009.02.010","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"2330_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ejso.2006.03.002","volume":"32","author":"FN Gilly","year":"2006","unstructured":"Gilly FN, Cotte E, Brigand C, Monneuse O, Beaujard AC, Freyer G, Glehen O (2006) Quantitative prognostic indices in peritoneal carcinomatosis. Eur J Surg Oncol 32(6):597\u2013601. https:\/\/doi.org\/10.1016\/j.ejso.2006.03.002","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"2330_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000371817","volume":"101","author":"L de Mestier","year":"2015","unstructured":"de Mestier L, Lardiere-Deguelte S, Brixi H, O\u2019Toole D, Ruszniewski P, Cadiot G, Kianmanesh R (2015) Updating the surgical management of peritoneal carcinomatosis in patients with neuroendocrine tumors. Neuroendocrinology 101(2):105\u2013111. https:\/\/doi.org\/10.1159\/000371817","journal-title":"Neuroendocrinology"},{"issue":"2","key":"2330_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington KM, Carneiro F, Cree IA, Board W.H.O.C.o.T.E. (2020) The 2019 WHO classification of tumours of the digestive system. Histopathology 76(2):182\u2013188. https:\/\/doi.org\/10.1111\/his.13975","journal-title":"Histopathology"},{"key":"2330_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Litiere S, de Vries E, Ford R, Gwyther S, Mandrekar S, Shankar L, Bogaerts J, Chen A, Dancey J et al (2016) RECIST 1.1-Update and clarification: from the RECIST committee. Eur J Cancer 62:132\u2013137. https:\/\/doi.org\/10.1016\/j.ejca.2016.03.081","journal-title":"Eur J Cancer"},{"issue":"6","key":"2330_CR15","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/01.sla.0000164073.08093.5d","volume":"241","author":"JP Boudreaux","year":"2005","unstructured":"Boudreaux JP, Putty B, Frey DJ, Woltering E, Anthony L, Daly I, Ramcharan T, Lopera J, Castaneda W (2005) Surgical treatment of advanced-stage carcinoid tumors: lessons learned. Ann Surg 241(6):839\u2013845. https:\/\/doi.org\/10.1097\/01.sla.0000164073.08093.5d. (discussion 845\u20136)","journal-title":"Ann Surg"},{"issue":"4","key":"2330_CR16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1159\/000287277","volume":"91","author":"M Pavel","year":"2010","unstructured":"Pavel M, Grossman A, Arnold R, Perren A, Kaltsas G, Steinmuller T, de Herder W, Nikou G, Plockinger U, Lopes JM et al (2010) ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors. Neuroendocrinology 91(4):326\u2013332. https:\/\/doi.org\/10.1159\/000287277","journal-title":"Neuroendocrinology"},{"issue":"1","key":"2330_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5306\/wjco.v2.i1.28","volume":"2","author":"EH Tan","year":"2011","unstructured":"Tan EH, Tan CH (2011) Imaging of gastroenteropancreatic neuroendocrine tumors. World J Clin Oncol 2(1):28\u201343. https:\/\/doi.org\/10.5306\/wjco.v2.i1.28","journal-title":"World J Clin Oncol"},{"issue":"3","key":"2330_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000471879","volume":"105","author":"A Sundin","year":"2017","unstructured":"Sundin A, Arnold R, Baudin E, Cwikla JB, Eriksson B, Fanti S, Fazio N, Giammarile F, Hicks RJ, Kjaer A et al (2017) ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological. Nucl Med Hybrid Imaging Neuroendocrinol 105(3):212\u2013244. https:\/\/doi.org\/10.1159\/000471879","journal-title":"Nucl Med Hybrid Imaging Neuroendocrinol"},{"issue":"11","key":"2330_CR19","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.2967\/jnumed.114.144386","volume":"55","author":"H Bahri","year":"2014","unstructured":"Bahri H, Laurence L, Edeline J, Leghzali H, Devillers A, Raoul JL, Cuggia M, Mesbah H, Clement B, Boucher E et al (2014) High prognostic value of 18F-FDG PET for metastatic gastroenteropancreatic neuroendocrine tumors: a long-term evaluation. J Nucl Med 55(11):1786\u20131790. https:\/\/doi.org\/10.2967\/jnumed.114.144386","journal-title":"J Nucl Med"},{"issue":"3","key":"2330_CR20","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1158\/1078-0432.CCR-09-1759","volume":"16","author":"T Binderup","year":"2010","unstructured":"Binderup T, Knigge U, Loft A, Federspiel B, Kjaer A (2010) 18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors. Clin Cancer Res 16(3):978\u2013985. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-1759","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2330_CR21","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.ejso.2022.03.019","volume":"48","author":"R Hajjar","year":"2022","unstructured":"Hajjar R, Mercier F, Passot G, Pasquer A, Gelli M, Levine EA, Villeneuve L, Poncet G, Walter T, Glehen O (2022) Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for small bowel neuroendocrine tumors with peritoneal metastasis. Eur J Surg Oncol 48(7):1626\u20131630. https:\/\/doi.org\/10.1016\/j.ejso.2022.03.019","journal-title":"Eur J Surg Oncol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02330-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02330-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02330-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T07:25:03Z","timestamp":1725261903000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02330-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":21,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["2330"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02330-5","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"28 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted retrospectively from data obtained for clinical purposes and was performed in line with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all the study participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}